Pharmacy Times

JULY 25, 2025

In 2023, 38.9 First-generation oral cephalosporins (ie, cephalexin and cefadroxil) have excellent coverage of methicillin-susceptible S aureus and Streptococcus spp, making them ideal agents for treatment. Typically, empiric coverage for UTIs includes Escherichia coli and Klebsiella pneumoniae.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 1, 2025

SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis. Because] insurance and cost barriers can be difficult for patients, pharmacists can help patients navigate copayment programs and the prior authorization process.”

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

Personalized drug selection can lead to faster symptom control, fewer hospitalizations, and improved adherence—all of which contribute to better outcomes and a more streamlined care process. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

Pharmacy Technician

Pharmacy Times

JUNE 16, 2025

The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers.

Pharmacy Technician

Pharmaceutical Technology

JUNE 23, 2025

In August 2023, the therapy received investigational new drug clearance from China’s National Medical Products Administration to start a Phase I cancer trial. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

AUGUST 12, 2025

Nanotein Technologies co-founder and CEO Curtis Hodge said: “Nanotein’s soluble activators are designed to improve cell therapy expansion by enhancing the quality and quantity of T cells and providing a feeder-free soluble activator for NK cell activation and expansion, addressing critical challenges in the manufacturing process.”

Insurance Coverage and Processing

Pharmacy Times

JULY 1, 2025

Rilonacept therapy management involves carefully evaluating patient disease stability, flare risks, and potential for discontinuation through a shared decision-making process. We on our own help to navigate patients through that process as well. That's an ongoing process, but that's one of the biggest questions.

Insurance Coverage and Processing

PharmaTech

AUGUST 1, 2025

All costs and expenses associated with Prize acceptance and use not specified herein as being provided such as reservation fees, taxes, insurance and other expenses incurred by accepting the Prize are the sole responsibility of the Winner. All federal, state, and local laws and regulations apply.

Dosage

Pharmaceutical Commerce

AUGUST 12, 2025

2 The following cases underscore the importance of diligence and vigilance in our procurement processes. Undoubtedly, the most significant recent case involving counterfeit drugs infiltrating the legitimate US supply chain was the 2021–2023 Gilead HIV medications case. April 14, 2025.

Packaging

Pharmacy Times

JULY 24, 2025

Someone ended up donating a car, and they used the money to buy tires and insurance. It seems to streamline the process,” Loy-Helm said. Because the pharmacy is in a rural area, Loy-Helm explained, patients have her phone number. One service at Russell Springs Pharmacy is pill packing. People love it.

Independent Pharmacies

Pharmaceutical Technology

JUNE 20, 2025

The latest funding boost supplements an earlier announcement made during the 2023-24 budget, which provided A$25m in recurrent funding dedicated to similar initiatives. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmacy Times

JULY 25, 2025

Insurance coverage for GLP-1 medications can be a barrier, as they are often not covered for non-diabetic uses, necessitating pharmacist guidance. 3 Of note, the CNBC article points to 2023 research published in the Journal of Clinical Medicine , which assessed women with PCOS and obesity receiving treatment with semaglutide.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 9, 2025

The first collaboration was announced in March 2023 for neurodegenerative diseases, and the second in December 2023 focused on discovering oligonucleotide therapeutics. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 25, 2025

According to GlobalData, the CGT market was estimated to be $5.88bn in 2023 and is projected to reach $80bn by 2029. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. GlobalData is the parent company of Clinical Trials Arena. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Beckers Hospital Review

JULY 17, 2025

to find out one specific way each of them has redesigned a process or care model in the past year to serve more patients — without adding staff. To meet this challenge, Infirmary Health redesigned its clinical documentation integrity process without adding staff. Alaska Mikal Canfield.

Insurance Coverage and Processing

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

Beckers Hospital Review

AUGUST 1, 2025

Mr. Angelone, co-founder and chief commercial officer of MacroHealth, has over 25 years of experience in the health insurance and technology industries. Mr. Angelone has also ensured compliance with key regulations like the No Surprises Act and Transparency in Coverage rules, promoting greater transparency in healthcare pricing.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

Corwin added that Dr. Verdun, who became OTP director in July 2023, is highly respected by industry and academic experts. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing

COE Integrated Care

MAY 7, 2025

An interesting parallel came in 2023 from Wendy Dean, co-founder of the non-profit Moral Injury of Healthcare, to work on clinician distress. On a smaller scale, treating these incidents as occupational hazards and allowing health care workers to process with their peers (Rabin et. 2023 Aug 16;15:153-160. J Healthc Leadersh.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 12, 2025

In 2023, SpliceBio signed a licensing agreement with Spark Therapeutics, allowing the latter to use its protein splicing platform and develop a gene therapy for an undisclosed inherited renal disease. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Express Pharma

AUGUST 31, 2023

This pivotal juncture has thrust cybersecurity into the spotlight in the discussions of companies during Q2 2023, revealing its paramount significance in safeguarding sensitive information, with regulation mentions getting on par with data protection, reveals the Company Filing Analytics Database of GlobalData.

Insurance Coverage and Processing

pharmaphorum

FEBRUARY 4, 2022

Lilly is a little vague on when it will now file donanemab with the FDA – suggesting on its fourth quarter 2021 results call that it may do so later this year – but reiterated that it has little hope of the drug being used ahead of the readout of TRAILBLAZER-ALZ 2 in mid-2023.

Insurance Coverage and Processing

Community Pharmacy

NOVEMBER 30, 2023

Created as an insurance coverage plan for those over 65, Medicare offers four levels of benefits that cover everything from hospital insurance to prescription medicine costs. 2024 Medicare Part D Costs Updates While the cost of Part D insurance premiums is expected to decrease from an average of $56.49 in 2023 to $55.50

Insurance Coverage and Processing

Putting Patients First Blog

JANUARY 4, 2024

The Abdominal Core Health Quality Collaborative (ACHQC) believes it is our obligation to listen and offer suggestions to help patients navigate the decision-making process. Choose a surgeon who communicates clearly, listens attentively, and ensures you understand the procedure, potential risks, and recovery process.

Insurance Coverage and Processing

Pharma in Brief

JULY 19, 2023

CADTH Time-Limited Reimbursement Recommendations Starting in the fall of 2023, CADTH, which conducts health technology assessments ( HTAs ) to inform public insurers, will introduce time-limited reimbursement recommendations for certain drug products. The deadline to provide input is August 18, 2023. Evidence-generation plans.

Insurance Coverage and Processing

Putting Patients First Blog

SEPTEMBER 3, 2024

The NHC appreciates CMS’ efforts to gather patient-centered data as part of this ICR and its commitment to making the process more relevant for patients and patient organizations. While we acknowledge these improvements, it is important to note that some aspects of the data collection process may remain challenging.

Drug Pricing

pharmaphorum

OCTOBER 1, 2022

In this latest coverage, pharmaphorum speaks with Eugene Borukhovich. If we look at insurers, during the kind of peak of the pandemic, insurers were not paying out, so, there was in theory lots of cash saved up for further investments. Augmented by technology, but not replaced by technology throughout that process.”.

Insurance Coverage and Processing

Putting Patients First Blog

JANUARY 10, 2024

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

Insurance Coverage and Processing

Putting Patients First Blog

FEBRUARY 1, 2024

In November 2023, the NHC submitted a letter to House and Senate leadership about the inclusion of health care transparency and affordability provisions in future spending packages. 5378 More Transparency, Lower Costs Act in December 2023. We reiterated these priorities to start the year in January 2024. The House passed H.R.

Insurance Coverage and Processing

pharmaphorum

JANUARY 28, 2021

Pharmacists have more insight into a patient’s insurance coverage than most providers, so this change could create a lot of value for patients throughout the country. We didn’t anticipate seeing interchangeability for biosimilars until 2023, when several biosimilars referencing Humira are slated to come market.

Biosimilars

Putting Patients First Blog

OCTOBER 15, 2023

As the primary insurer for millions of Americans and as the programs that drive decisions throughout the health ecosystem, these federal programs can be a critical driver of innovations. Finally, the timing of the scoring process can be frustrating when working to advance good policy. Best Price).

Insurance Coverage and Processing

The Thyroid Pharmacist

AUGUST 4, 2023

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. However, some may be concerned with this genetic information getting reported on insurance or to employers.

Insurance Coverage and Processing

Putting Patients First Blog

JULY 2, 2024

We believe that patient-centric engagement is essential to ensure that the negotiation process leads to outcomes that genuinely benefit patients. Patient Engagement The NHC recognizes and commends CMS’ willingness to improve the listening sessions and the data submission processes. Improving the Data Collection (ICR) Process.

Drug Pricing

Putting Patients First Blog

JANUARY 27, 2025

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.

Insurance Coverage and Processing

Putting Patients First Blog

JUNE 5, 2023

This is not a venue that patients and their advocates have access to, as health insurance plans are the primary users of the portal. CMS must ensure stakeholders have ample opportunity to provide input throughout the implementation and adjustment process. A simple 30-day comment period process will likely not be sufficient.

Insurance Coverage and Processing

Putting Patients First Blog

MAY 29, 2024

As of 2023, 30.8 1 This trend underscores the importance of informed decision-making for those with chronic diseases and disabilities, who face crucial choices regarding their health care coverage – whether selecting between traditional Medicare and MA, choosing among MA plans, or navigating their selected plan to access necessary care.

Insurance Coverage and Processing

Putting Patients First Blog

MARCH 4, 2024

Under the new Manufacturer Discount Program, manufacturers will be required to provide discounts on applicable drugs during the initial coverage phase and catastrophic phase of the defined standard Part D drug benefit.

Insurance Coverage and Processing